Chen Y, Cai Q and Liu S Anal Biochem. 2019 Sep 30;587:113467. doi: 10.1016/j.ab.2019.113467.
Publications & Posters - Oncology
Analytical Biochemistry | September 30, 2019
Methods in molecular biology | September 10, 2019
Cohen L, Keegan A and Walt DR
Serum Neurofilament Light, Glial Fibrillary Acidic Protein and Tau Are Possible Serum Biomarkers for Activity of Brain Metastases and Gliomas
World Journal of Oncology Volume 10, Number 4-5, October 2019, pages 169-175 | September 09, 2019
Hepner A, Porter J, Hare F, Nasir SS, Zetterberg H, Blennow K and Martin MG World Journal of Oncology, September 9, 2019, doi: https://doi.org/10.14740/wjon1228
Phase 1b trial of docetaxel, prednisone, and pazopanib in men with metastatic castration‐resistant prostate cancer
The Prostate | September 09, 2019
George DJ, Halabi S, Healy P, Barak I, Winters C, Anand M, Wilder R, Klein M, Martinez E, Nixon AB, Harrison MR, Szmulewitz R and Armstrong AJ
High Coping Self-Efficacy Associated With Lower Sweat Inflammatory Cytokines in Adults: A Pilot Study
Biological Research For Nursing | September 05, 2019
Hladek M, Gill J, Lai C, Lorig K and Szanton S Biological Research For Nursing September 5, doi: https://doi.org/10.1177/1099800419870607
Circulating interferon‐α measured with a highly sensitive assay as a biomarker for juvenile inflammatory myositis activity
Arthritis & Rheumatology | September 05, 2019
Melki I, Devilliers H, Gitiaux C, Bondet V, Belot A, Bodemer C, Quartier P, Crow YJ, Duffy D, Rodero MP and Bader Meunier B Arthritis Rheumatol. 2019 Sep 5. doi: 10.1002/art.41096.
A Comprehensive, Multidisciplinary, Precision Medicine Approach to Discover Effective Therapy for an Undiagnosed, Progressive, Fibro-inflammatory Disease
Translational Research | August 28, 2019
Gochuico BR, Ziegler SG, Ten NS, Balanda NJ, Mason CE, Zumbo P, Evans CA, Van Waes C, Gahl WA and Malicdan MCV. Translational Research. 28 August 2019 doi: https://doi.org/10.1016/j.trsl.2019.08.008
A phase Ib study of the combination regorafenib with PF-03446962 in patients with refractory metastatic colorectal cancer (REGAL-1 trial).
Cancer Chemother Pharmacol. 2019. | August 23, 2019
Clarke JM, Blobe GC, Strickler JH, Uronis HE, Zafar SY, Morse M, Dropkin E, Howard L, O'Neill M, Rushing CN, Niedzwiecki D, Watson H, Bolch E, Arrowood C, Liu Y, Nixon AB and Hurwitz HI
Methods | August 23, 2019
Chen J, Sagum C and Bedford MT Methods. 2019 Aug 23. pii: S1046-2023(19)30137-9. doi: 10.1016/j.ymeth.2019.08.007.
JCI insight | August 22, 2019
Mendelson A, Strat AN, Bao W, Rosston P, Fallon G, Ohrn S, Zhong H, Lobo C, An X and Yazdanbakhsh K. JCI Insight. 2019 Aug 22;4(16). pii: 126982. doi: 10.1172/jci.insight.126982.